The potential health and economic effect of a Body Mass Index decrease in the overweight and obese population in Belgium

Public Health

Volumn 134, Issue , 2016, Pages 26-33

  Verhaeghe, N ^a,b   De Greve, O ^c   Annemans, L ^a  

^a GHENT UNIVERSITY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c Weight Watchers NV   (Belgium)

Author keywords

Body Mass Index; Health economic evaluation; Markov model; Obesity; Overweight

Indexed keywords

BODY MASS; ECONOMIC IMPACT; HEALTH IMPACT; MARKOV CHAIN; NUMERICAL MODEL; OBESITY; SENSITIVITY ANALYSIS;

ADULT; AGED; ARTICLE; BELGIUM; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; COST CONTROL; ECONOMIC EVALUATION; FEMALE; HEALTH; HEALTH CARE COST; HEALTH IMPACT ASSESSMENT; HUMAN; MALE; MARKOV DECISION ANALYTIC MODEL; MATHEMATICAL MODEL; OBESITY; OUTCOME ASSESSMENT; PROBABILITY; RESOURCE ALLOCATION; SENSITIVITY ANALYSIS; ECONOMIC MODEL; ECONOMICS; HEALTH STATUS; MARKOV CHAIN; MIDDLE AGED; OVERWEIGHT; RISK; STATISTICS AND NUMERICAL DATA;

BELGIUM;

AGED; BELGIUM; BODY MASS INDEX; COST SAVINGS; FEMALE; HEALTH STATUS; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, ECONOMIC; OBESITY; OVERWEIGHT; RISK;

EID: 84959104125     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2016.01.015     Document Type: Article

References (48)

1. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
2. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. J Am Med Assoc 2012, 307:491-497.
3. World Health Organization Obesity: preventing and managing the global epidemic 2004, World Health Organization, Geneva.
4. Van der Heyden J., Gisle L., Demarest S., Drieskens S., Hesse E., Tafforeau J. Health interview survey Belgium 2008 2010, Scientific Institute for Public Health, Brussels.
5. Alwan A., MacLean D.R., Riley L.M., d'Espaignet E.T., Mathers C.D., Stevens G.A., et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2010, 376:1861-1868.
6. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007, 29:1-5.
7. Monteiro C.A., Moura E.C., Conde W.L., Popkin B.M. Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ 2004, 82:940-946.
8. Haslam D.W., James W.P. Obesity. Lancet 2005, 366:1197-1209.
9. Konnopka A., Bodemann M., König H.H. Health burden and costs of obesity and overweight in Germany. Eur J Health Econ 2011, 12:345-352.
10. Drummond M., Sculpher M., Torrance G., O'Brien B., Stoddart G. Methods for the economic evaluation of health care programmes 2005, Oxford University Press, Oxford. 3rd ed.
11. De Smedt D., De Cocker K., Annemans L., De Bourdeaudhuij I., Cardon G. A cost-effectiveness study of the community-based intervention '10 000 Steps Ghent'. Public Health Nutr 2012, 15:442-451.
12. Verhaeghe N., De Smedt D., De Maeseneer J., Maes L., Van Heeringen C., Annemans L. Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care. BMC Public Health 2014, 14:856.
13. Rijksinstituut voor Volksgezondheid en Milieu (RIVM) 2011, 16-6-2013. http://www.nationaalkompas.nl/gezondheid-en-ziekte/ziekten-en-aandoeningen/.
14. Belgian Cancer Registry Tabellen op jaarbasis 2010, 15-6-2013. http://www.kankerregister.org/.
15. International association for the study of obesity 2012, http://worldobesity.org.
16. Ubink-Veltmaat L.J., Bilo H.J., Groenier K.H., Houweling S.T., Rischen R.O., Meyboom-de J.B. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol 2003, 18:793-800.
17. Vaartjes I., van D I., Grobbee D.E., Bots M.L. The dynamics of mortality in follow-up time after an acute myocardial infarction, lower extremity arterial disease and ischemic stroke. BMC Cardiovasc Disord 2010, 10:57.
18. Devroey D., Van C V., Buntinx F. Registration of stroke through the Belgian sentinel network and factors influencing stroke mortality. Cerebrovasc Dis 2003, 16:272-279.
19. Intego Registratienetwerk van huisartsen in Vlaanderen 2010, 14-6-2013. http://www.intego.be.
20. Belgian Cancer Registry Cancer survival in Belgium 2012, Belgian Cancer Registry, Brussels. http://www.kankerregister.org/.
21. Schienkiewitz A., Schulze M.B., Hoffmann K., Kroke A., Boeing H. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2006, 84:427-433.
22. McGee D.L. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005, 15:87-97.
23. Kurth T., Gaziano J.M., Berger K., Kase C.S., Rexrode K.M., Cook N.R., et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002, 162:2557-2562.
24. Rosengren A., Wilhelmsen L., Lappas G., Johansson S. Body mass index, coronary heart disease and stroke in Swedish women. A prospective 19-year follow-up in the BEDA study. Eur J Cardiovasc Prev Rehabil 2003, 10:443-450.
25. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.
26. Green L.E., Dinh T.A., Smith R.A. An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk. Comput Math Methods Med 2012, 2012:792375.
27. Williams R., Van G.L., Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002, 45:S13-S17.
28. Annemans L., Lamotte M., Clarys P., Van den Abeele E. Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases. Eur J Cardiovasc Prev Rehabil 2007, 14:815-824.
29. Annemans L., Marbaix S., Webb K., Van G.L., Scheen A. Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative atorvastatin diabetes study in the belgian population. Clin Drug Invest 2010, 30:133-142.
30. Kimman M.L., Dirksen C.D., Voogd A.C., Falger P., Gijsen B.C., Thuring M., et al. Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer 2011, 47:1175-1185.
31. Leal J., Luengo-Fernandez R., Gray A., Petersen S., Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006, 27:1610-1619.
32. Steuten L.M., Vrijhoef H.J., Landewe-Cleuren S., Schaper N., Van Merode G.G., Spreeuwenberg C. A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets. Diabet Med 2007, 24:1112-1120.
33. Koopmanschap M.A., Rutten F.F. The consequence of production loss or increased costs of production. Med Care 1996, 34:DS59-DS68.
34. Cleemput I., Crott R., Vrijens F., Huybrechts M., Van Wilder P., Ramaekers D. Voorlopige richtlijnen voor farmaco-economisch onderzoek in België 2006, Health Technology Assessment (HTA), KCE Report 28A (D/2006/10.273/10) edn, Belgian Health Care Knowledge Centre (KCE), Brussels.
35. Korhonen P.E., Seppala T., Jarvenpaa S., Kautiainen H. Body mass index and health-related quality of life in apparently healthy individuals. Qual Life Res 2014, 23:67-74.
36. Heyworth I.T., Hazell M.L., Linehan M.F., Frank T.L. How do common chronic conditions affect health-related quality of life?. Br J Gen Pract 2009, 59:e353-e358.
37. Karnon J., Jones T. A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patients. Pharmacoeconomics 2003, 21:513-525.
38. Ko C.Y., Maggard M., Livingston E.H. Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment. J Surg Res 2003, 114:1-5.
39. Federal Public Service Economy Structuur van de bevolking volgens leeftijd en geslacht: België 2013, 15-6-2013. http://economie.fgov.be/nl/statistieken/cijfers/bevolking/structuur/leeftijdgeslacht/belgie/.
40. Cleemput I., Neyt M., Thiry N., De Laet C., Leys M. Threshold values for cost-effectiveness in health care 2008, Health Technology Assessment (HTA). KCE Report 100C (D/2008/10.273/96) edn, Belgian Health Care Knowledge Centre (KCE), Brussels.
41. Briggs A., Claxton K., Sculpher M. Decision modelling for health economic evaluation 2006, Oxford University Press, Oxford.
42. Siebert U., Alagoz O., Bayoumi A.M., Jahn B., Owens D.K., Cohen D.J., et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Value Health 2012, 15:812-820.
43. Dixon J.B. The effect of obesity on health outcomes. Mol Cell Endocrinol 2010, 316:104-108.
44. Muller-Riemenschneider F., Reinhold T., Berghofer A., Willich S.N. Health-economic burden of obesity in Europe. Eur J Epidemiol 2008, 23:499-509.
45. Ul-Haq Z., Mackay D.F., Fenwick E., Pell J.P. Meta-analysis of the association between body mass index and health-related quality of life among adults, assessed by the SF-36. Obes (Silver Spring) 2013, 21:E322-E327.
46. Avenell A., Brown T.J., McGee M.A., Campbell M.K., Grant A.M., Broom J., et al. What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions. J Hum Nutr Diet 2004, 17:293-316.
47. Annemans L. Health economics for non-economists. An introduction to the concepts, methods and pitfalls of health economic evaluations 2008, Academia Press, Ghent.
48. Briggs A.H., Weinstein M.C., Fenwick E.A., Karnon J., Sculpher M.J., Paltiel A.D., et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health 2012, 15:835-842.